{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:44:09Z","timestamp":1787013849558,"version":"build-2736575974"},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BIAL Pharmaceutical"},{"name":"EISAI Inc"},{"name":"Esteve laboratorios"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1111\/ane.12809","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T05:22:44Z","timestamp":1503379364000},"page":"67-75","source":"Crossref","is-referenced-by-count":22,"title":["Outcome of cancer-related seizures in patients treated with lacosamide"],"prefix":"10.1155","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3208-2496","authenticated-orcid":false,"given":"M.","family":"Toledo","sequence":"first","affiliation":[{"name":"Epilepsy Unit; Neurolog\u00fd Department; Hospital Universitario Vall d\u2032Hebron; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Molins","sequence":"additional","affiliation":[{"name":"Epilepsy Unit; Neurology Department; Hospital Universitari Vall d\u2032Hebron; Girona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Quintana","sequence":"additional","affiliation":[{"name":"Epilepsy Unit; Neurolog\u00fd Department; Hospital Universitario Vall d\u2032Hebron; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Santamarina","sequence":"additional","affiliation":[{"name":"Epilepsy Unit; Neurolog\u00fd Department; Hospital Universitario Vall d\u2032Hebron; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Martinez-Ricarte","sequence":"additional","affiliation":[{"name":"Neurosurgery Department; Hospital Universitario Vall d\u2032Hebron; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mart\u00ednez-Saez","sequence":"additional","affiliation":[{"name":"Neuropathology Department; Hospital Universitario Vall d\u2032Hebron; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Salas-Puig","sequence":"additional","affiliation":[{"name":"Epilepsy Unit; Neurolog\u00fd Department; Hospital Universitario Vall d\u2032Hebron; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"issue":"9","key":"10.1111\/ane.12809-BIB0001|ane12809-cit-0001","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(12)70266-8","article-title":"Epilepsy meets cancer: when, why, and what to do about it?","volume":"13","author":"Weller","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1111\/ane.12809-BIB0002|ane12809-cit-0002","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1634\/theoncologist.2014-0060","article-title":"Seizure prognosis in brain tumors: new insights and evidence-based management","volume":"19","author":"Vecht","year":"2014","journal-title":"Oncologist"},{"key":"10.1111\/ane.12809-BIB0003|ane12809-cit-0003","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/neuonc\/not057","article-title":"Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme","volume":"15","author":"Kerkhof","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1111\/ane.12809-BIB0004|ane12809-cit-0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ane.12437","article-title":"Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics","volume":"133","author":"Gefroh-Grimes","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12809-BIB0005|ane12809-cit-0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.yebeh.2013.07.024","article-title":"Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide","volume":"29","author":"Villanueva","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12809-BIB0006|ane12809-cit-0006","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ane.12221","article-title":"Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome","volume":"129","author":"Grosso","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12809-BIB0007|ane12809-cit-0007","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejpn.2013.08.006","article-title":"Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy","volume":"18","author":"Grosso","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1111\/ane.12809-BIB0008|ane12809-cit-0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yebeh.2016.09.033","article-title":"NEOPLASM study: real-life use of lacosamide in patients with brain tumor-related epilepsy","volume":"65","author":"Villanueva","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12809-BIB0009|ane12809-cit-0009","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1007\/s00415-011-6132-8","article-title":"Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability","volume":"258","author":"Maschio","year":"2011","journal-title":"J Neurol"},{"key":"10.1111\/ane.12809-BIB0010|ane12809-cit-0010","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3171\/2013.1.JNS12397","article-title":"Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors","volume":"118","author":"Saria","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1111\/ane.12809-BIB0011|ane12809-cit-0011","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1007\/s00415-013-7133-6","article-title":"Usefulness of intravenous lacosamide in status epilepticus","volume":"260","author":"Santamarina","year":"2013","journal-title":"J Neurol"},{"key":"10.1111\/ane.12809-BIB0012|ane12809-cit-0012","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.yebeh.2014.05.015","article-title":"Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study","volume":"36","author":"Garc\u00e9s","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1111\/ane.12809-BIB0013|ane12809-cit-0013","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1528-1167.2007.01317.x","article-title":"Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures","volume":"49","author":"Biton","year":"2008","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12809-BIB0014|ane12809-cit-0014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"WHO Classification of Tumours of the Central Nervous System","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1111\/ane.12809-BIB0015|ane12809-cit-0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.crad.2014.03.012","article-title":"Neuroimaging in status epilepticus secondary to paraneoplastic autoimmune encephalitis","volume":"69","author":"Sarria-Estrada","year":"2014","journal-title":"Clin Radiol"},{"key":"10.1111\/ane.12809-BIB0016|ane12809-cit-0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2016.12.013","article-title":"Epileptic features and survival in glioblastomas presenting with seizures","volume":"130","author":"Toledo","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12809-BIB0017|ane12809-cit-0017","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1750-3639.2012.00582.x","article-title":"Long-term epilepsy-associated tumors","volume":"22","author":"Thom","year":"2012","journal-title":"Brain Pathol"},{"issue":"SUPPL. 9","key":"10.1111\/ane.12809-BIB0018|ane12809-cit-0018","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12437","article-title":"Seizure characteristics and prognostic factors of gliomas","volume":"54","author":"Kerkhof","year":"2013","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12809-BIB0019|ane12809-cit-0019","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1528-1167.2007.01188.x","article-title":"Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12809-BIB0020|ane12809-cit-0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.eplepsyres.2013.05.002","article-title":"Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: a single centre evaluation","volume":"106","author":"Novy","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12809-BIB0021|ane12809-cit-0021","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.seizure.2011.01.004","article-title":"Combining antiepileptic drugs - Rational polytherapy?","volume":"20","author":"Brodie","year":"2011","journal-title":"Seizure"},{"key":"10.1111\/ane.12809-BIB0022|ane12809-cit-0022","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma","volume":"77","author":"Weller","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/ane.12809-BIB0023|ane12809-cit-0023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/WNP.0b013e31829ddcdb","article-title":"Spectrum of nonconvulsive status epilepticus in patients with cancer","volume":"30","author":"Spindler","year":"2013","journal-title":"J Clin Neurophysiol"},{"key":"10.1111\/ane.12809-BIB0024|ane12809-cit-0024","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0404.2010.01430.x","article-title":"Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus","volume":"123","author":"Koubeissi","year":"2011","journal-title":"Acta Neurol Scand"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12809","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12809\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:50:46Z","timestamp":1671522646000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12809","archive":["Portico"],"relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,22]]}}}